Fairvalue-Calculator Fairvalue-Calculator
EN DE

d1000 Varejo Farma Participações S.A (DMVF3) Fair Value & Analysis

Healthcare · BR · Market cap R$347M

PriceR$6.82
Fair ValueR$15.32
Upside+124.6%
Quality95/100
Evidence: High Range R$8.30 – R$17.12

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

d1000 Varejo Farma Participações S.A (DMVF3) currently trades at R$6.82, while our model-based Fair Value estimate is R$15.32 — implying the stock looks roughly 124.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

d1000 Varejo Farma Participações S.A. engages in the retail sale of pharmaceutical and perfumery products in Brazil. It sells generic drugs, OTC, and personal care and beauty products. The company was formerly known as Cancun RJ Participações S/A and changed its name to d1000 Varejo Farma Participações S.A. in March 2016. The company was incorporated in 2010 and is headquartered in Rio De Janeiro, Brazil. d1000 Varejo Farma Participações S.A. is a subsidiary of Profarma Distribuidora de Produtos Farmacêuticos S.A.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is d1000 Varejo Farma Participações S.A (DMVF3) undervalued?
As of Jun 25, 2026, our model estimates a fair value of R$15.32 versus a price of R$6.82 — about +125% (undervalued). Model-based estimate, not financial advice.
What is the fair value of DMVF3?
Our 21-model fair value for d1000 Varejo Farma Participações S.A is R$15.32 (as of Jun 25, 2026), built from audited fundamentals. The current price is R$6.82.
What is the quality score of DMVF3?
d1000 Varejo Farma Participações S.A has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.